News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
94,268 Results
Type
Article (3058)
Company Profile (52)
Press Release (91158)
Multimedia
Podcasts (3)
Webinars (1)
Section
Business (36375)
Career Advice (66)
Deals (6043)
Drug Delivery (10)
Drug Development (12531)
Employer Resources (10)
FDA (2463)
Job Trends (2354)
News (55683)
Policy (3681)
Tag
Academia (243)
Accelerated approval (1)
Adcomms (2)
Allergies (21)
Alliances (4479)
ALS (10)
Alzheimer's disease (234)
Antibody-drug conjugate (ADC) (23)
Approvals (2510)
Artificial intelligence (31)
Automation (2)
Bankruptcy (36)
Best Places to Work (2123)
BIOSECURE Act (1)
Biosimilars (11)
Biotechnology (38)
Bladder cancer (31)
Brain cancer (2)
Breast cancer (70)
Cancer (496)
Cardiovascular disease (60)
Career advice (60)
CAR-T (13)
CDC (8)
Cell therapy (51)
Cervical cancer (4)
Clinical research (11136)
Collaboration (92)
Compensation (111)
Complete response letters (3)
COVID-19 (340)
CRISPR (7)
C-suite (23)
Cystic fibrosis (16)
Data (665)
Depression (10)
Diabetes (60)
Diagnostics (973)
Digital health (9)
Diversity, equity & inclusion (6)
Drug discovery (12)
Drug pricing (11)
Drug shortages (1)
Duchenne muscular dystrophy (18)
Earnings (29164)
Editorial (3)
Employer resources (11)
Events (11490)
Executive appointments (44)
FDA (2954)
Frontotemporal dementia (5)
Funding (87)
Gene editing (14)
Generative AI (4)
Gene therapy (34)
GLP-1 (127)
Government (459)
Grass and pollen (2)
Guidances (248)
Healthcare (2690)
HIV (6)
Huntington's disease (2)
IgA nephropathy (8)
Immunology and inflammation (25)
Immuno-oncology (3)
Indications (6)
Infectious disease (372)
Inflammatory bowel disease (17)
Inflation Reduction Act (1)
Influenza (15)
Intellectual property (14)
Interviews (7)
IPO (3985)
IRA (2)
Job creations (338)
Job search strategy (54)
Kidney cancer (4)
Labor market (8)
Layoffs (46)
Leadership (2)
Legal (635)
Liver cancer (11)
Longevity (1)
Lung cancer (83)
Lymphoma (59)
Machine learning (1)
Management (1)
Manufacturing (54)
MASH (26)
Medical device (2384)
Medtech (2387)
Mergers & acquisitions (2142)
Metabolic disorders (141)
Multiple sclerosis (20)
NASH (1)
Neurodegenerative disease (10)
Neuropsychiatric disorders (3)
Neuroscience (332)
NextGen: Class of 2025 (719)
Non-profit (476)
Now hiring (2)
Obesity (56)
Opinion (13)
Ovarian cancer (20)
Pain (14)
Pancreatic cancer (14)
Parkinson's disease (24)
Patents (26)
Patient recruitment (38)
Peanut (9)
People (3819)
Pharmaceutical (8)
Pharmacy benefit managers (2)
Phase I (2729)
Phase II (4388)
Phase III (4626)
Pipeline (973)
Policy (18)
Postmarket research (529)
Preclinical (824)
Press Release (2)
Prostate cancer (27)
Psychedelics (2)
Radiopharmaceuticals (34)
Rare diseases (61)
Real estate (532)
Recruiting (4)
Regulatory (2949)
Reports (15)
Research institute (226)
Resumes & cover letters (6)
RSV (11)
Schizophrenia (20)
Series A (16)
Series B (10)
Service/supplier (2)
Sickle cell disease (13)
Special edition (2)
Spinal muscular atrophy (22)
Sponsored (2)
Startups (357)
Stomach cancer (2)
Supply chain (5)
Tariffs (2)
The Weekly (3)
Vaccines (153)
Venture capital (5)
Weight loss (31)
Women's health (4)
Date
Today (14)
Last 7 days (39)
Last 30 days (242)
Last 365 days (4975)
2025 (3510)
2024 (5973)
2023 (6901)
2022 (7874)
2021 (8607)
2020 (8086)
2019 (6487)
2018 (5251)
2017 (4745)
2016 (3726)
2015 (5210)
2014 (3479)
2013 (2303)
2012 (2473)
2011 (2867)
2010 (2429)
Location
Africa (78)
Alabama (9)
Arizona (40)
Asia (5946)
Australia (557)
California (1776)
Canada (298)
China (91)
Colorado (55)
Connecticut (51)
Delaware (65)
Europe (11672)
Florida (179)
Georgia (38)
Idaho (2)
Illinois (98)
India (4)
Indiana (81)
Japan (42)
Kansas (36)
Kentucky (6)
Louisiana (7)
Maine (11)
Maryland (192)
Massachusetts (871)
Michigan (41)
Minnesota (130)
Mississippi (1)
Missouri (16)
Montana (3)
Nebraska (3)
Nevada (15)
New Hampshire (25)
New Jersey (400)
New York (263)
North Carolina (180)
Northern California (1038)
Ohio (27)
Oklahoma (2)
Oregon (2)
Pennsylvania (244)
Puerto Rico (1)
Rhode Island (1)
South America (123)
South Carolina (1)
Southern California (457)
Tennessee (42)
Texas (166)
United States (5100)
Utah (32)
Virginia (20)
Washington D.C. (5)
Washington State (112)
West Virginia (1)
Wisconsin (6)
94,268 Results for "65".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dualitas Launches With $65 Million Series A to Advance Novel Bispecific Antibody Pipeline in Immune and Inflammatory Disease
September 16, 2025
·
5 min read
Press Releases
I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares
August 4, 2025
·
5 min read
Press Releases
Tevogen Estimates 5-Year Top-Line Revenue of ∼$6.5 Billion For Product Focused on Liver Cancer Prevention with High-Risk Chronic Hepatitis B Infection
September 10, 2025
·
3 min read
Press Releases
Zomedica Announces First Quarter 2025 Financial Results: Revenue of $6.5 Million; 68% Gross Margin, and $65 Million in Liquidity to Support Growth
May 15, 2025
·
13 min read
Press Releases
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
August 28, 2025
·
19 min read
Press Releases
Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering
May 29, 2025
·
7 min read
Press Releases
Generic Sterile Injectable Market Size to Reach USD 119.65 Bn by 2034 High Demand for Low-cost Treatments and Chronic Disease Prevalence
July 7, 2025
·
1 min read
Press Releases
Plasma Protein Therapeutic Market worth US$ 52.82 billion by 2032 with 6.5% CAGR | Coherent Market Insights
June 12, 2025
·
1 min read
Press Releases
Visby Medical™ Raises up to $65 Million in New Financing Round to Accelerate Launch of Groundbreaking At-Home Sexually Transmitted Infections (STI) Test
June 17, 2025
·
4 min read
Press Releases
HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases
May 8, 2025
·
5 min read
1 of 9,427
Next
